Oxford Instruments (LON:OXIG – Get Free Report) released its earnings results on Tuesday. The company reported GBX 42.60 earnings per share for the quarter, Digital Look Earnings reports. The business had revenue of £201.10 million for the quarter. Oxford Instruments had a return on equity of 13.94% and a net margin of 11.39%.
Here are the key takeaways from Oxford Instruments’ conference call:
- Oxford Instruments reported a strong first half: orders rose 44%, revenue increased 9% at constant currency, adjusted operating profit grew 28%, and the group operating margin advanced 160 basis points to 14.9%.
- Advanced Technologies orders more than doubled to £132 million, with revenue up around 27% and its operating margin reaching 7.5%. The company now expects around 20% revenue growth in FY 2028 and says the division should reach its 12%–15% medium-term margin range earlier than previously expected.
- Imaging and Analysis orders grew 12.6% at constant currency, rebuilding the order book and improving cover for the second half. Management expects low-single-digit revenue growth for the full year, assuming orders continue at a similar pace.
- Management flagged execution risks as Advanced Technologies scales, including supply-chain constraints and the need to add and train staff; it also cautioned that the operating environment remains uncertain. Continued U.S. weakness in academic healthcare and life-sciences demand and currency headwinds are additional pressures.
Oxford Instruments Stock Performance
OXIG opened at GBX 2,640 on Wednesday. Oxford Instruments has a twelve month low of GBX 1,850 and a twelve month high of GBX 3,318. The firm has a market capitalization of £1.44 billion, a PE ratio of 31.54, a PEG ratio of -3.56 and a beta of 1.09. The company has a current ratio of 1.83, a quick ratio of 1.11 and a debt-to-equity ratio of 13.08. The firm’s 50-day moving average price is GBX 2,764.23 and its 200 day moving average price is GBX 2,776.04.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Oxford Instruments
Insider Transactions at Oxford Instruments
In other Oxford Instruments news, insider Richard Tyson bought 65 shares of the firm’s stock in a transaction on Thursday, September 10th. The shares were acquired at an average cost of GBX 2,731 per share, with a total value of £1,775.15. Also, insider Paul Fry bought 66 shares of the stock in a transaction dated Thursday, September 10th. The shares were bought at an average price of GBX 2,731 per share, for a total transaction of £1,802.46. 1.56% of the stock is currently owned by corporate insiders.
Oxford Instruments Company Profile
Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science. Innovation is the driving force behind Oxford Instruments’ growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world. The vigorous search for new ways to make our world greener, healthier and more productive is driving unprecedented levels of R&D investment in new materials and techniques to support productivity and decarbonisation worldwide, creating a significant opportunity for Oxford Instruments to grow.
See Also
- Five stocks we like better than Oxford Instruments
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
Receive News & Ratings for Oxford Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Instruments and related companies with MarketBeat.com's FREE daily email newsletter.
